An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the TMC114-C215 study is to evaluate the safety and tolerability of
TMC114/RTV over time. The secondary objectives are to evaluate the antiviral activity over
time and to evaluate the immunological effect over time.